Sign in or register to see full information and data.

Studies / CAVD 498

Overview

Study information

Network:CAVD
Grant Affiliation:Pantaleo: RepliVax Vaccine Platform
Strategy:Combo: DNA, protein & vector vaccines
Study Type:Pre-Clinical NHP
Species:Rhesus macaque
Stage:Assays Completed
Study Start Date:2015-06-10
Study Made Public:2017-07-27

Title

RepliVax Immunogenicity NHP Pilot Study

Description

CAVD 498 is a non-human primate study comparing protein, DNA, NYVAC, and RepliVax‚Äč prime/boost regimens.

Products

MF59 gp120 C.1086 gp120 TV1 DNA-HIV-PT123 NYVAC-HIV-PT1 NYVAC-HIV-PT4 RepliVax

Integrated data

BAMA, ICS, NAb

Non-integrated data

No non-integrated data is available for this study.